Signaling changes in the stem cell factor-AKT-S6 pathway in diagnostic AML samples are associated with disease relapse. | Blood Cancer J;1(2): e3, 2011 Feb. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Signaling changes in the stem cell factor-AKT-S6 pathway in diagnostic AML samples are associated with disease relapse.

Kornblau, S M; Covey, T; Putta, S; Cohen, A; Woronicz, J; Fantl, W J; Gayko, U; Cesano, A.

Blood Cancer J ; 1(2): e3, 2011 Feb.

Article in En | MEDLINE | ID: mdl-22829109

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Risk_factors_studies Language: En Journal: Blood Cancer J Year: 2011 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Risk_factors_studies Language: En Journal: Blood Cancer J Year: 2011 Document type: Article